Your browser doesn't support javascript.
loading
Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression.
Wyrobnik, Iris; Steinberg, Miryam; Gelfand, Anat; Rosenblum, Ronen; Eid Mutlak, Yara; Sulimani, Liron; Procaccia, Shiri; Ofran, Yishai; Novak-Kotzer, Hila; Meiri, David.
Affiliation
  • Wyrobnik I; The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Steinberg M; The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Gelfand A; The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Rosenblum R; The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Eid Mutlak Y; The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Sulimani L; The Kleifeld Laboratory, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Procaccia S; Cannasoul Analytics, Caesarea, Israel.
  • Ofran Y; The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Novak-Kotzer H; Department of Hematology, Shaare Zedek Medical Center and Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Meiri D; The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Oncoimmunology ; 12(1): 2219164, 2023.
Article in En | MEDLINE | ID: mdl-37325437
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Macrophage Colony-Stimulating Factor / Melanoma Type of study: Prognostic_studies Language: En Journal: Oncoimmunology Year: 2023 Type: Article Affiliation country: Israel
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Macrophage Colony-Stimulating Factor / Melanoma Type of study: Prognostic_studies Language: En Journal: Oncoimmunology Year: 2023 Type: Article Affiliation country: Israel